Position in IBRX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$4,377
+$542 QoQ
Shares Held
500
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 104 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tradewinds Capital Management, LLC holds $130,589 across 18 Biotechnology names. IBRX ranks #6 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRSP |
CRISPR Therapeutics AG
|
1,073 | $58,521 | |
| 2 | SLS |
SELLAS Life Sciences Group, Inc.
|
1,000 | $14,760 | |
| 3 | ABCL |
AbCellera Biologics Inc.
|
1,837 | $14,420 | |
| 4 | QURE |
uniQure N.V.
|
200 | $9,212 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
100 | $7,827 | |
| 6 | IBRX |
ImmunityBio, Inc.
This page
|
500 | $4,377 | |
| 7 | ARDX |
Ardelyx, Inc.
|
816 | $4,161 | |
| 8 | VYGR |
Voyager Therapeutics, Inc.
|
1,000 | $3,500 |
All Filings in IBRX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,377 | 500 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $3,835 | 500 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $990 | 500 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $1,230 | 500 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,320 | 500 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,505 | 500 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,280 | 500 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $1,860 | 500 | Shares | Sole | 2024-10-16 | |
| No filing history on record for this holder in this stock. | ||||||